Vesalio’s pVasc Mechanical Thrombectomy System Launched in United States

September 4, 2024—Vesalio announced the United States commercialization of pVasc thrombectomy system for nonsurgically removing peripheral occlusions.

Vesalio stated that pVasc is indicated for arteries from 2 to 6 mm in diameter, typically located below the knee, in the femoropopliteal, the mesenteric, the upper extremities, and a few other locations. The pVasc device is composed of a self-expanding nitinol structure on a pusher wire.

According to the company, pVasc targets the full range of embolisms from soft, acute clots to fibrin-rich, calcified ones, enabling a fast and safe removal. Its Drop Zone technology traps, retains, and securely removes thrombus to restore flow in patients with acute limb ischemia (ALI) and other conditions related to peripheral artery disease.

“Given the complicated health history of patients with ALI, physicians often face the challenge of delivering devices through highly diseased arteries and working in small, stenotic vessels,” commented Frank Arko, MD, in the company’s press release. “pVasc has a low profile and excellent deliverability, making it an especially valuable tool when access is difficult or when working in arteries below the knee.”

Dr. Arko is Chief, Vascular and Endovascular Surgery and Co-Director of the Aortic Institute at Carolinas Medical Center, Sanger Heart and Vascular Institute in Charlotte, North Carolina.

Nick Abedi, MD, a vascular surgeon at Fayette Surgical Associates in Lexington, Kentucky, added, “I have achieved highly positive results with pVasc in challenging cases that range from organized emboli in the tibials to emboli in the brachial and distal ulnar artery. pVasc has helped my patients avoid open surgery on multiple occasions, becoming an invaluable tool in my practice.”